Udupi’s Anupama launches political party in Ballari; vows liquor-free Karnataka

coastaldigest.com news network
November 1, 2017

Ballari, Nov 1: Former police officer Anupama Shenoy, who could not get expected support from the BJP even after making a series of allegations against the Congress government of Karnataka, on Wednesday launched her own political party at Kudligi in Ballari district. 

Formally launching Bharatiya Jana Shakthi Congress (BJSC), Anupama said that the new party intends to make the Karnataka a liquor-free state in stages. She said that her party would endorse Mahatma Gandhiji's concept of Gram Swarajya. 

A few weeks ago, Anupama had claimed that her new party would contest all 224 seats in 2018 Karnataka Assembly polls. A couple of days ago, she stated that her party would field candidates in 80 seats across Karnataka. However, on the day of party launch, she said that the details of how many seats her party would contest and from which districts will be decided at a later date.

Anupama, who hails from Udupi district, was serving as the Deputy Superintendent of Police in Kudligi sub-division when she quit the police department. She had accused the senior officers of harassing her and not forcing her to withdraw resignation.

Anupama is one of the three children of Radhakrishna (63), who runs a canteen at Uchila village in Udupi district. Her elder brother Aravind is an electronics engineer in Malaysia and the other Achutha is a field engineer. After BSc, Anupama completed Masters in Social Work before clearing the KAS examination.

Comments

sharief
 - 
Thursday, 2 Nov 2017

lets hope for the best 4 this party to  b transperent n  b far away from any religious leader(cast no bar)

Althaf
 - 
Wednesday, 1 Nov 2017

Super star upendra also launched his new political party. I hope BJP votes will divide and BJP will vanish from indian politics. People of india including Bhakts must realise that BJP is only good for industrialist not for common people.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 21,2020

Jan 21: Info Edge (India)'s shareholding in Zomato reduces to 22.71%; Uber receives 9.99% stake in Zomato.

Info Edge (India) announced that Zomato Media (Zomato) has signed a definitive agreement to acquire Uber's food delivery business in India (Uber) in an all-stock transaction, which gives Uber 9.99% ownership in Zomato.

Uber Eats in India will discontinue operations and direct restaurants, delivery partners, and users of the Uber Eats apps to the Zomato platform, effective 21 January 2020.

Upon closing of said acquisition, the company's shareholding in Zomato shall stand reduced to about 22. 71 % on fully converted & diluted basis.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 10,2020

Mysuru, Jul 9: The renowned Mysore Palace has been closed on Thursday after a relative of an employee at the palace was tested COVID-19 positive, an official said.

The palace has been closed for the visitors in the view of rising COVID-19 cases. Authorities have decided to re-open the palace on Monday.

Earlier the Palace was closed for tourists for a week from March 15 to 22, in the wake of the coronavirus outbreak, Mysore Palace committee said.

According to the Union Health Ministry, Karnataka has reported 28,877 COVID-19 positive cases including 16,531 active, 11,876 cured/discharged/migrated while 470 succumbed to the virus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.